Galera Therapeutics, Inc.
OBX-115
melanoma
Resolved
68days ago
FDA decision · ~ Apr 30, 2026 estimated
What's at stake
An FDA complete response letter on OBX-115 for melanoma is in focus around ~ Apr 30, 2026.
Primary source
· SEC 8-K
verified 17h ago
“CRL: April 2026”